Naeem Tahirkheli is a Cardiology physician affiliated with Oklahoma Heart Hospital. OpenAlex indexes 48 publications with 1,741 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5224 E I 240 Service Rd Ste 201
Oklahoma City, OK 731352607
Telephone
405-608-3800Provider last certified this registry record 6 Jun 2022.
Industry payments
35 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20259 payments
- Teleflex LLCProgram year20255 payments
- Shockwave Medical, IncProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
65.1%Statin17.4%Atorvastatin Calcium61%Rosuvastatin Calcium31%Pravastatin Sodium4%Simvastatin2%Livalo1%Pitavastatin Calcium1%Part D<11 patientsBeta blocker14.3%Metoprolol Succinate40%Metoprolol Tartrate31%Carvedilol21%Atenolol3%Nebivolol Hcl2%Propranolol Hcl2%Propranolol Hcl Er1%Sotalol1%Part D<11 patients+ 20 more classes in this area
Metabolism & gastrointestinal
15.2%Proton pump inhibitor4.3%Pantoprazole Sodium57%Omeprazole40%Esomeprazole Magnesium3%Part D<11 patientsPotassium supplement4%Potassium Chloride97%Klor-Con 104%Part D<11 patients+ 9 more classes in this area
Blood & clotting
13.3%P2Y12 inhibitor7.2%Clopidogrel77%Prasugrel Hcl19%Brilinta4%Part D≥288 patientsFactor Xa inhibitor4.9%Eliquis77%Xarelto23%Part D≥150 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Prognostic impact of tricuspid regurgitation improvement after transcatheter mitral valve replacement: results from an international multicentre registry
European Heart Journal - Valvular and Structural Heart Disease
2026 - Outcomes of High-Dose Intracoronary Adenosine Protocol in Saphenous Venous Graft Percutaneous Coronary Intervention: A 15-Year Single-Center Experience
Journal of the Society for Cardiovascular Angiography & Interventions
2026 - Etripamil Nasal Spray for Recurrent Paroxysmal Supraventricular Tachycardia Conversion: Results From the NODE‐303 Open‐Label Study
Journal of Cardiovascular Electrophysiology
2025 - Transcatheter Mitral Valve Replacement With Atrial Fixation for Treatment of Atrial Functional Mitral Regurgitation
Circulation Cardiovascular Interventions
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Beau Hawkins, MD
Oklahoma Heart Hospital
Paul Garabelli, MD
Oklahoma Heart Hospital
Soni Zacharias, MD
Oklahoma Heart Hospital
James Males, MD
Oklahoma Heart Hospital
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”